The Effect of Oral High-dose Ibuprofen on Patent Ductus Arteriosus Closure in Preterm Infants

American Journal of Perinatology

Volumn 32, Issue 12, 2015, Pages 1158-1163

  Pourarian, Shahnaz ^a   Takmil, Faranak ^b   Cheriki, Sirous ^c   Amoozgar, Hamid ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Premature PDA High Dose Ibuprofen

Indexed keywords

CREATININE; IBUPROFEN; UREA; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLEEDING TENDENCY; CESAREAN SECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GENDER; GESTATIONAL AGE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; SEPSIS; SIDE EFFECT; STEROID THERAPY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; DOPPLER ECHOCARDIOGRAPHY; DUCTUS ARTERIOSUS, PATENT; ECHOGRAPHY; IRAN; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; IRAN; MALE;

EID: 84943457269     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1551671     Document Type: Article

References (25)

1. Koch J., Hensley G., Roy L., Brown S., Ramaciotti C., Rosenfeld C. R. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics: 2006; 117 4 1113 1121
2. Ellison R. C., Peckham G. J., Lang P., et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics: 1983; 71 3 364 372
3. Rojas M. A., Gonzalez A., Bancalari E., Claure N., Poole C., Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr: 1995; 126 4 605 610
4. Jones R. W., Pickering D. Persistent ductus arteriosus complicating the respiratory distress syndrome. Arch Dis Child: 1977; 52 4 274 281
5. Supapannachart S., Limrungsikul A., Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai: 2002; 85 4 04 S1252 S1258
6. Pourarian Sh, Pishva N., Madani A., Rastegari M. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants. East Mediterr Health J: 2008; 14 2 360 365
7. Lee C. H., Chen H. N., Tsao L. Y., Hsiao C. C., Lee M. L. Oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants. Pediatr Neonatol: 2012; 53 6 346 353
8. Yadav S., Agarwal S., Maria A., et al. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatr Cardiol: 2014; 35 5 824 830
9. Dani C., Vangi V., Bertini G., et al. High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther: 2012; 91 4 590 596
10. Desfrere L., Zohar S., Morville P., et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther: 2005; 30 2 121 132
11. Hirt D., Van Overmeire B., Treluyer J-M., et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol: 2008; 65 5 629 636
12. Gregory K. E., Deforge C. E., Natale K. M., Phillips M., Van Marter L. J. Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation. Adv Neonatal Care: 2011; 11 3 155 164, quiz 165-166
13. Sasi A., Deorari A. Patent ductus arteriosus in preterm infants. Indian Pediatr: 2011; 48 4 301 308
14. Yang E. M., Song E. S., Choi Y. Y. Comparison of oral Ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants. J Pediatr (Rio J): 2013; 89 1 33 39
15. Patel J., Roberts I., Azzopardi D., Hamilton P., Edwards A. D. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res: 2000; 47 1 36 42
16. Van Overmeire B., Smets K., Lecoutere D., et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med: 2000; 343 10 674 681
17. Guzoglu N., Sari F. N., Ozdemir R., et al. Renal and mesenteric tissue oxygenation in preterm infants treated with oral ibuprofen. J Matern Fetal Neonatal Med: 2014; 27 2 197 203
18. Neumann R., Schulzke S. M., Bührer C. Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology: 2012; 102 1 9 15
19. Erdeve O., Yurttutan S., Altug N., et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed: 2012; 97 4 F279 F283
20. Aranda J. V., Varvarigou A., Beharry K., et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr: 1997; 86 3 289 293
21. Van Overmeire B., Touw D., Schepens P. J., Kearns G. L., van den Anker J. N. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther: 2001; 70 4 336 343
22. Richards J., Johnson A., Fox G., Campbell M. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics: 2009; 124 2 e287 e293
23. Pezzati M., Vangi V., Biagiotti R., Bertini G., Cianciulli D., Rubaltelli F. F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr: 1999; 135 6 733 738
24. Soldin O. P., Chung S. H., Mattison D. R. Sex differences in drug disposition. J Biomed Biotechnol: 2011; 2011 187103
25. Whitley H., Lindsey W. Sex-based differences in drug activity. Am Fam Physician: 2009; 80 11 1254 1258